Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Chile - an attractive market after healthcare reforms

This article was originally published in Clinica

Executive Summary

Big market opportunities and fewer import restrictions await companies selling to Latin America, says Silvia Dreyfuss, general manager of the US/Latin America biomedical trading company, LABS. Speaking at the Institute of the Americas' Latin American Health Care Congress, she also listed the disadvantages of dealing with the region, which include slow product introduction and payment delays from customers of between 60 and 120 days.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts